Dolasetron-induced torsades de pointes

Journal of Clinical Anesthesia

Volumn 19, Issue 8, 2007, Pages 622-625

  Turner, Sarah ^a   Mathews, Letha ^a   Pandharipande, Pratik ^a   Thompson, Reid ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

5HT3 blockers; Dolasetron; Graves' disease; Meningioma; Torsade de pointes; Vasopressors

Indexed keywords

AMIODARONE; DOLASETRON MESILATE; ETOMIDATE; FENTANYL; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; ISOFLURANE; LOSARTAN; METOPROLOL; PROPOFOL; SUFENTANIL; SUXAMETHONIUM; THIAMAZOLE; VASOPRESSIN; VECURONIUM;

ADULT; ARTERIAL GAS; ARTICLE; BLOOD PRESSURE MONITORING; CASE REPORT; DEFIBRILLATION; ELECTROCARDIOGRAM; ENDOTRACHEAL INTUBATION; FEMALE; GRAVES DISEASE; HEMODYNAMICS; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; LABORATORY TEST; MENINGIOMA; MUSCLE RELAXATION; OPERATING ROOM; PEROPERATIVE CARE; PRIORITY JOURNAL; RESUSCITATION; SURGICAL TECHNIQUE; TORSADE DES POINTES;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTIEMETICS; CARDIOPULMONARY RESUSCITATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; HYPERTENSION; HYPOTENSION; INDOLES; INTRAOPERATIVE COMPLICATIONS; INTUBATION, INTRATRACHEAL; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPANOLAMINES; QUINOLIZINES; RISK FACTORS; TORSADES DE POINTES; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 36849025612     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2007.03.012     Document Type: Article

References (10)

1. Kao L., Kirk M., Evers S., and Rosenfeld S. Droperidol, QT prolongation, and sudden death: what is the evidence?. Ann Emerg Med 41 (2003) 546-558
2. Charbit B., Albaladejo P., Funck-Brentano C., Legrand M., Samain E., and Marty J. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 102 (2005) 1094-1100
3. Cubeddu L. QT Prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am J Ther 10 (2003) 452-457
4. Hart J., and Stonier P.D. Dolasetron and peri-operative cardiac arrhythmia. Anaesthesia 60 (2005) 937-938
5. White P., Song D., Abrao J., Klein K., and Navarette B. Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study. Anesthesiology 102 (2005) 1101-1105
6. Kantor G. Arrhythmia risk of antiemetic agents. Anesthesiology 97 (2002) 286
7. Benedict C.R., Arbogast R., Martin L., Patton L., Morrill B., and Hahne W. Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers. J Cardiovasc Pharmacol 28 (1996) 53-59
8. Miller D.R. Arrythmogenic potential of antiemetics: perspectives on risk-benefits. Can J Anaesth 50 (2003) 215-220
9. Higgins D.J., and Bunker N.J. Dolasetron and peri-operative cardiac arrhythmia. Anaesthesia 60 (2005) 936-937
10. Roden D.M. Drug induced prolongation of the QT interval. N Engl J Med 350 (2004) 1013-1022